Tin diferente manera pa trata kanser di kolon, dependiendo di e fase i gravedat di e malesa.
Algun tratamentu komun ta:
1. Operashon: Esaki ta e tratamentu mas komun pa kanser di kolon.
E kírùg ta kita e parti di e kolon ku tin kanser i e ganglionnan limfátiko den bisindario.
Den algun kaso, por kita un parti chikitu di e kolon saludabel na kada banda di e kanser.
2. Kimo: E tratamentu aki ta usa droga pa mata sèlnan di kanser.
E por wòrdu duná promé òf despues di un operashon, òf den kombinashon ku terapia di radiashon.
Terapia di radiashon: E tratamentu aki ta usa radiashon di energia haltu pa mata sèlnan di kanser.
E por wòrdu usá promé òf despues di un operashon, òf den kombinashon ku kímika.
Terapia dirigí: E tratamentu aki ta usa medikamentu ku ta dirigí riba molekülnan spesífiko ku ta enbolbí den kresementu i plamamentu di sèlnan di kanser.
Hopi biaha ta uza esaki den kombinashon ku kímoterapia.
5. Immunoterapia: E tratamentu aki ta yuda e sistema imunológiko rekonosé i ataká e sèlnan di kanser.
Hopi biaha ta usa esaki huntu ku otro tratamentu.
Kuido paliativo: E tipo di kuido aki ta enfoká riba aliviá síntoma i mehorá kalidat di bida di pashèntnan ku kanser di kolon avansá.
E por inkluí tratamentu di doló, sosten nutritivo i sosten emoshonal.
Ta importante pa papia ku un profeshonal di kuido médiko tokante e mihó opshonnan di tratamentu, pasobra e aserkamentu di mas efektivo ta dependé di e situashon spesífiko di e persona.
Tu Z, Ma Y, Akers W, Achilefu S, Gu Y: Therapeutic effect of the treatment for colorectal cancer with adenoviral vectors mediated estrogen receptor β gene therapy combined with thermotherapy. J Cancer Res Clin Oncol. 2014, 140 (4): 623-32.
Kim YE, Kwon S, Wu G, Kim D, Park BK, Park JA, Choi KC, Kim DS, Kwon HJ, Lee Y: Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model. Oncotarget. 2014, 5 (18): 8402-15.
Khan FA, Albalawi R, Pottoo FH: Trends in targeted delivery of nanomaterials in colon cancer diagnosis and treatment. Med Res Rev. 2022, 42 (1): 227-258.
Kwon S, Kim YE, Park JA, Kim DS, Kwon HJ, Lee Y: Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse model. BMB Rep. 2014, 47 (4): 215-20.
Viale PH: Expanded treatment options in the adjuvant therapy of colon cancer: implications for oncology nurses. Oncol Nurs Forum. 2006, 33 (1): 81-90.
Ortiz R, Prados J, Melguizo C, Rama AR, Alvarez PJ, Rodríguez-Serrano F, Caba O, Boulaiz H, Aranega A: Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells. Biomed Pharmacother. 2012, 66 (7): 563-7.
['Disclaimer: médiko']
['E website aki ta pa informashon i edukashon so i no ta pa duna konseho médiko òf servisio profeshonal.']
['E informashon ku ta ser duná no mester ser usá pa diagnostiká òf trata un problema di salú òf malesa, i esnan ku ta buska konseho médiko personal mester konsultá ku un dòkter ku tin un pèrmit di traha.']
['Por fabor nota e reda neuronal ku ta generá kontesta na e preguntanan, ta spesialmente inakusá ora ta trata di kontenido numériko. Por ehèmpel, e kantidat di hende diagnostiká ku un malesa spesífiko.']
['Semper busca conseho di bo dokter of otro profesional di salud cualifica tocante un condicion medico. Nunca ignora conseho medico profesional of tarda pa busca esaki pa motibo di algo cu bo a lesa riba e website aki. Si bo ta kere cu bo por tin un emergencia medico, yama 911 of bay na e sala di emergencia mas cerca di bo mesora.']
['Copyright: Copyright']
['E Digital Millennium Copyright Act di 1998, 17 U.S.C. § 512 (e DMCA) ta duna derechi di rekurso pa doñonan di derechi di outor ku ta kere ku material ku ta aparesé riba internet ta violá nan derechi bou di lei di derechi di outor di Merka. ']
['Si bo ta kere di buena fe ku kualke kontenido òf material ku ta disponibel riba nos website òf servisio ta violá bo derechi di outor, abo (òf bo representante) por manda nos un notifikashon pa pidi pa kita e kontenido òf material òf pa blokia akseso na dje.']
["Mester manda e anunsio por eskrito via e-mail (wak e sekshon 'Kontacto' pa e-mail adrès)."]
['E DMCA ta eksigí ku bo notifikashon di violashon di derechi di outor ta inkluí e siguiente informashon: (1) deskripshon di e obra ku ta suheto di violashon; (2) deskripshon di e kontenido ku ta viola i informashon sufisiente pa nos por lokalisá e kontenido; (3) informashon di kontakto, inkluyendo bo adrès, number di telefòn i email; (4) un deklarashon di bo ku bo ta kere ku e kontenido no ta outorisá pa e doño di derechi di outor, su agente òf lei.']
['(5) un deklarashon di bo, firma bou di pena di huramentu falsu, ku e informashon den e notifikashon ta korekto i ku bo tin outoridat pa hasi uso di e derechonan di outor ku ta ser akusá di a wòrdu infringi;']
['i (6) un firma físiko òf elektróniko di e doño di derechi di outor òf un persona outorisá pa aktua na nòmber di e doño di derechi di outor.']
['Si bo no duna tur informashon ariba menshoná, e tratamentu di bo keho por tarda.']
['Kontakto']
['Por fabor manda nos un email ku kualke pregunta/sugerencia.']
How to treat colon cancer?
There are several ways to treat colon cancer, depending on the stage and severity of the disease.
Some common treatments include:
1. Surgery: This is the most common treatment for colon cancer.
The surgeon removes the cancerous part of the colon and nearby lymph nodes.
In some cases, a small part of the healthy colon on either side of the cancer may also be removed.
2. Chemotherapy: This treatment uses drugs to kill cancer cells.
It can be given before or after surgery, or in combination with radiation therapy.
3. Radiation therapy: This treatment uses high-energy radiation to kill cancer cells.
It can be used before or after surgery, or in combination with chemotherapy.
4. Targeted therapy: This treatment uses drugs that target specific molecules involved in the growth and spread of cancer cells.
It is often used in combination with chemotherapy.
5. Immunotherapy: This treatment helps the immune system to recognize and attack cancer cells.
It is often used in combination with other treatments.
6. Palliative care: This type of care focuses on relieving symptoms and improving the quality of life for patients with advanced colon cancer.
It may include pain management, nutritional support, and emotional support.
It is important to discuss the best treatment options with a healthcare professional, as the most effective approach will depend on the individual's specific situation.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Tokante']
['BioMedLib ta usa kòmpiuter outomátiko (algoritmo di siñamentu di mashin) pa generá par di pregunta i kontesta.']
['Nos ta kuminsá ku 35 mion publikashon biomédico di PubMed/Medline. Tambe página di RefinedWeb.']
